News and Updates

New Phase 3 data reveals that XIAFLEX significantly improves symptoms of plantar fibromatosis, offering a potential non-surgical breakthrough for patients.

OKYO Pharma receives positive FDA feedback on its lead ocular candidate, OK-101. Learn how this regulatory milestone impacts the future of dry eye treatment.

Turn Therapeutics stock surges after promising AD clinical trial results. Learn how the company is expanding its pipeline to tackle chronic skin conditions.

Theriva Biologics gains Spanish approval for Phase 2a trials of VCN-01. Learn how this novel oncolytic virus targets treatment-resistant pancreatic cancer.

The FDA has granted Priority Review to Agios Pharmaceuticals’ mitapivat for Sickle Cell Disease. Learn how this PK activator could transform SCD treatment.

The FDA has greenlit a single Phase 3 trial for ATH434, potentially accelerating the approval process for a new Multiple System Atrophy treatment.

The EMA has fast-tracked the review of daraxonrasib for metastatic pancreatic cancer, potentially offering new hope for treatment-resistant patients.

Vertex Pharmaceuticals faces mounting pressure to integrate its $10B expansion strategy. Explore the impact on R&D, clinical trials, and biotech innovation.

A new oral weight loss pill has outperformed Ozempic in recent clinical trials. Discover the impact of this promising discovery on obesity treatment.

Discover how a new five-agent AI system is revolutionizing clinical trial design by rapidly analyzing real-world patient records to accelerate research.